The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi

Journal of Cutaneous Pathology

Volumn 37, Issue SUPPL. 1, 2010, Pages 26-40

  Lu, Song ^a   Slominski, Andrzej ^b   Yang, Sung Eun ^a   Sheehan, Christine ^a   Ross, Jeffrey ^a   Carlson, J Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BIOLOGICAL MARKER; MESSENGER RNA; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITF PROTEIN, HUMAN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HAIR FOLLICLE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MALE; MELANOCYTE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIGMENTED NEVUS; SCAR; SKIN TUMOR;

ADULT; AGED; ALPHA-MSH; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CICATRIX; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTES; MALE; MELANOCYTES; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; NEVUS, PIGMENTED; RNA, MESSENGER; SKIN NEOPLASMS; TRPM CATION CHANNELS; YOUNG ADULT;

EID: 77949833132     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01504.x     Document Type: Article

References (70)

1. Duncan LM, Deeds J, Hunter J, et al. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998 58 : 1515.
2. Entrez gene: TRPM1 transient receptor potential cation channel, subfamily M, member 1 [database on the Internet] [accessed April 7, 2009]. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView& TermToSearch=4308
3. Hunter JJ, Shao J, Smutko JS, et al. Chromosomal localization and genomic characterization of the mouse melastatin gene (Mlsn1). Genomics 1998 54 : 116.
4. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007 87 : 165.
5. Xu XZ, Moebius F, Gill DL, Montell C. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform. Proc Natl Acad Sci USA 2001 98 : 10692.
6. Bellone RR, Brooks SA, Sandmeyer L, et al. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus). Genetics 2008 179 : 1861.
7. Deeds J, Cronin F, Duncan LM. Patterns of melastatin mRNA expression in melanocytic tumors. Hum Pathol 2000 31 : 1346.
8. Duncan LM, Deeds J, Cronin FE, et al. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol 2001 19 : 568.
9. Fang D, Setaluri V. Expression and up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells. Biochem Biophys Res Commun 2000 279 : 53.
10. Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res 2004 64 : 509.
11. Hoek KS, Schlegel NC, Eichhoff OM, et al. Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 2008 21 : 665.
12. King R, Googe PB, Weilbaecher KN, Mihm MC Jr., Fisher DE. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 2001 25 : 51.
13. King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for Melanoma Diagnosis. Am J Pathol 1999 155 : 731.
14. Steingrimsson E, Copeland NG, Jenkins NA. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 2004 38 : 365.
15. Levy C, Khaled M, Fisher DE. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006 12 : 406.
16. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005 436 : 117.
17. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007 445 : 851.
18. Wellbrock C, Marais R. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol 2005 170 : 703.
19. Selzer E, Wacheck V, Lucas T, et al. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Cancer Res 2002 62 : 2098.
20. Hammock L, Cohen C, Carlson G, et al. Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma. J Cutan Pathol 2006 33 : 599.
21. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004 84 : 1155.
22. White RM, Zon LI. Melanocytes in development, regeneration, and cancer. Cell Stem Cell 2008 3 : 242.
23. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998 22 : 976.
24. Cochran AJ. The incidence of melanocytes in normal human skin. J Invest Dermatol 1970 55 : 65.
25. Fallowfield ME, Curley RK, Cook MG. Melanocytic lesions and melanocyte populations in human epidermis. Br J Dermatol 1991 124 : 130.
26. Breathnach A. An atlas of of the ultrastructure of human skin. London : Churchill, 1971.
27. Szabo G. Quantitative histological investigation on the melanocyte system in the human epidermis. In Gordon M, ed. Pigment cell biology. New York : Academic Press, 1959 99.
28. Mishima Y, Sheldon W. Enzymically active and inactive melanocyte populations and ultraviolet irradiation: combined dopa-premelanin reaction and electron microscopy. J Invest Dermatol 1967 49 : 273.
29. Dean NR, Brennan J, Haynes J, Goddard C, Cooter RD. Immunohistochemical labeling of normal melanocytes. Appl Immunohistochem Mol Morphol. 2002 10 : 199.
30. Breathnach A. Melanocytes in early regenerated human epidermis. J Invest Dermatol 1960 35 : 245.
31. Velangi SS, Rees JL. Why are scars pale? An immunohistochemical study indicating preservation of melanocyte number and function in surgical scars. Acta Derm Venereol 2001 81 : 326.
32. Botella-Estrada R, Sanmartin O, Sevila A, Escudero A, Guillen C. Melanotic pigmentation in excision scars of melanocytic and non-melanocytic skin tumors. J Cutan Pathol 1999 26 : 137.
33. Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002 138 : 77.
34. Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 1979 73 : 141.
35. Scheibner A, McCarthy WH, Milton GW, Nordlund JJ. Langerhans cell and melanocyte distribution in "normal" human epidermis. Preliminary report. Australas J Dermatol 1983 24 : 9.
36. Staricco RJ, Pinkus H. Quantitative and qualitative data on the pigment cells of adult human epidermis. J Invest Dermatol 1957 28 : 33.
37. Rosdahl I, Rorsman H. An estimate of the melanocyte mass in humans. J Invest Dermatol 1983 81 : 278.
38. Stierner U, Rosdahl I, Augustsson A, Kagedal B. UVB irradiation induces melanocyte increase in both exposed and shielded human skin. J Invest Dermatol 1989 92 : 561.
39. Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol 2006 142 : 871.
40. Acker SM, Nicholson JH, Rust PF, Maize JC. Morphometric discrimination of melanoma in situ of sun-damaged skin from chronically sun-damaged skin. J Am Acad Dermatol 1998 39 : 239.
41. Barlow JO, Maize J Sr., Lang PG. The density and distribution of melanocytes adjacent to melanoma and nonmelanoma skin cancers. Dermatol Surg 2007 33 : 199.
42. Wong CK. A study of melanocytes in the normal skin surrounding malignant melanomata. Dermatologica 1970 141 : 215.
43. Gleason BC, Crum CP, Murphy GF. Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts. J Cutan Pathol 2008 35 : 615.
44. Slominski A, Wortsman J, Plonka PM, Schallreuter KU, Paus R, Tobin DJ. Hair follicle pigmentation. J Invest Dermatol 2005 124 : 13.
45. Slominski A, Paus R, Plonka P, et al. Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dermatol 1996 106 : 1203.
46. Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 2005 307 : 720.
47. Rosdahl I. The epidermal melanocyte population and its reaction to ultraviolet light. Acta Derm Venereol Suppl (Stockh) 1979 88 : 1.
48. Montagna W, Chase HB. Histology and cytochemistry of human skin. X. X-irradiation of the scalp. Am J Anat 1956 99 : 415.
49. Staricco RG. Amelanotic melanocytes in the outer sheath of the human hair follicle and their role in the repigmentation of regenerated epidermis. Ann NY Acad Sci 1963 100 : 239.
50. Carlson JA, Ross JS, Slominski AJ. New techniques in dermatopathology that help to diagnose and prognosticate melanoma. Clin Dermatol 2009 27 : 75.
51. Slominski A. Cooling skin cancer: menthol inhibits melanoma growth. Focus on "TRPM8 activation suppresses cellular viability in human melanoma". Am J Physiol 2008 295 : C293.
52. Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005 10 : 153.
53. Carlson JA, Linette GP, Aplin A, Ng B, Slominski A. Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin 2007 25 : 541, viii.
54. Grichnik JM, Burch JA, Burchette J, Shea CR. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 1998 111 : 233.
55. Berking C, Takemoto R, Satyamoorthy K, et al. Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. Cancer Res 2004 64 : 807.
56. Noonan FP, Dudek J, Merlino G, De Fabo EC. Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Res 2003 16 : 16.
57. North JP, Kageshita T, Pinkel D, Leboit PE, Bastian BC. Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol 2008 128 : 2024.
58. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953 6 : 963.
59. Carlson JA, Scott D, Wharton J, Sell S. Incidental histopathologic patterns: possible evidence of 'field cancerization' surrounding skin tumors. Am J Dermatopathol. 2001 23 : 494.
60. Slominski A. Coming of age of melanogenesis-related proteins. Arch Pathol Lab Med 2002 126 : 775.
61. Busam KJ. The use and application of special techniques in assessing melanocytic tumours. Pathology 2004 36 : 462.
62. Smoller BR, Hsu A, Krueger J. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 1991 18 : 315.
63. Abdel-Naser MB, Krasagakis K, Garbe C, Eberle J. Direct effects on proliferation, antigen expression and melanin synthesis of cultured normal human melanocytes in response to UVB and UVA light. Photodermatol Photoimmunol Photomed 2003 19 : 122.
64. Skelton HG 3rd, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol 1991 13 : 543.
65. Smoller BR, McNutt NS, Hsu A. HMB-45 recognizes stimulated melanocytes. J Cutan Pathol 1989 16 : 49.
66. Lommel K, Tronnier M, Wolff HH. [Activation of epidermal melanocytes is independent of epithelial proliferation and vascularization. Immunohistologic study using HMB-45 antibody with review of the literature]. Hautarzt 1996 47 : 616.
67. Carlson JA, Grabowski R, Mu XC, Del Rosario A, Malfetano J, Slominski A. Possible mechanisms of hypopigmentation in lichen sclerosus. Am J Dermatopathol 2002 24 : 97.
68. Boissy RE, Zhao H, Oetting WS, et al. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet 1996 58 : 1145.
69. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992 11 : 519.
70. Virador V, Matsunaga N, Matsunaga J, et al. Production of melanocyte-specific antibodies to human melanosomal proteins: expression patterns in normal human skin and in cutaneous pigmented lesions. Pigment Cell Res 2001 14 : 289.